In our latest national research study, the Uvence team have been looking into whether the pandemic has accelerated the ageing process.
Our research, which has been published in the likes of The Times and The Telegraph, over 6 MILLION Brits feel they look at LEAST five years older due to pandemic stress and anxiety.
Not only this, but over 1 in 3 Brits report that they are experiencing visible signs of premature ageing since lockdown, particularly around their eyes. With this in mind, it’s not surprising to hear that there’s been such a dramatic increase in demand for cosmetic treatments in recent months.
But whilst there are many Brits keen to book their clinic appointments, there are many more who are interested in cosmetic treatments, but are wary of the use of synthetic substances in the most popular procedures, such as fillers and Botox.
Uvence’s research has found that over 6 million people in Britain report an interest in getting a cosmetic procedure, but haven’t done so because they don’t want to introduce unnatural substances into their bodies.
Uvence is a revolutionary service which caters to the need for natural treatments, combining micro-fat extraction, purification and cryogenic preservation to offer a 100% natural filler.
The treatment harnesses the body’s self-repair mechanism – your own purified live cells – to reset the ageing process and eliminate the possibility of rejection or botched results. After extracting and purifying a small quantity of a patient’s fat to make “Super Enriched Tissue”, Uvence creates 100% natural injectables which can be used anywhere on the body to visibly rejuvenate, smooth and soften skin almost immediately, which lasts for several months.
Not only does the treatment represent a completely natural alternative, but it also provides a long-term solution – the “Super Enriched Tissue” can be cryo-preserved for up to 5 years, meaning that patients can benefit from multiple injections to boost their skin over the course of several years. The service is already available in a number of London-based clinics, and is being rolled out to clinics across the UK later this year.